These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 24247554

  • 1. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
    Poole J, Mavromatis K, Binongo JN, Khan A, Li Q, Khayata M, Rocco E, Topel M, Zhang X, Brown C, Corriere MA, Murrow J, Sher S, Clement S, Ashraf K, Rashed A, Kabbany T, Neuman R, Morris A, Ali A, Hayek S, Oshinski J, Yoon YS, Waller EK, Quyyumi AA.
    JAMA; 2013 Dec 25; 310(24):2631-9. PubMed ID: 24247554
    [Abstract] [Full Text] [Related]

  • 2. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial.
    McDermott MM, Ferrucci L, Tian L, Guralnik JM, Lloyd-Jones D, Kibbe MR, Polonsky TS, Domanchuk K, Stein JH, Zhao L, Taylor D, Skelly C, Pearce W, Perlman H, McCarthy W, Li L, Gao Y, Sufit R, Bloomfield CL, Criqui MH.
    JAMA; 2017 Dec 05; 318(21):2089-2098. PubMed ID: 29141087
    [Abstract] [Full Text] [Related]

  • 3. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial.
    McDermott MM, Polonsky TS, Guralnik JM, Ferrucci L, Tian L, Zhao L, Stein J, Domanchuk K, Criqui MH, Taylor DA, Li L, Kibbe MR.
    J Am Heart Assoc; 2019 Jan 22; 8(2):e011001. PubMed ID: 30661439
    [Abstract] [Full Text] [Related]

  • 4. Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
    Mehta A, Mavromatis K, Ko YA, Rogers SC, Dhindsa DS, Goodwin C, Patel R, Martini MA, Prasad M, Mokhtari A, Hesaroieh IG, Frohwein SC, Kutner MH, Harzand A, Wells BJ, Duwayri Y, Alabi O, Rajani RR, Brewster LP, Waller EK, Quyyumi AA.
    Contemp Clin Trials; 2020 Apr 22; 91():105975. PubMed ID: 32145440
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.
    Subramaniyam V, Waller EK, Murrow JR, Manatunga A, Lonial S, Kasirajan K, Sutcliffe D, Harris W, Taylor WR, Alexander RW, Quyyumi AA.
    Am Heart J; 2009 Jul 22; 158(1):53-60.e1. PubMed ID: 19540392
    [Abstract] [Full Text] [Related]

  • 6. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK, Levy M.
    Vasc Med; 2013 Aug 22; 18(4):234-6. PubMed ID: 23867841
    [Abstract] [Full Text] [Related]

  • 7. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.
    McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ.
    JAMA; 2013 Jul 03; 310(1):57-65. PubMed ID: 23821089
    [Abstract] [Full Text] [Related]

  • 8. Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.
    Domanchuk K, Ferrucci L, Guralnik JM, Criqui MH, Tian L, Liu K, Losordo D, Stein J, Green D, Kibbe M, Zhao L, Annex B, Perlman H, Lloyd-Jones D, Pearce W, Taylor D, McDermott MM.
    Contemp Clin Trials; 2013 Nov 03; 36(2):502-9. PubMed ID: 24080099
    [Abstract] [Full Text] [Related]

  • 9. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA.
    JAMA; 2013 Feb 06; 309(5):453-60. PubMed ID: 23385271
    [Abstract] [Full Text] [Related]

  • 10. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial.
    McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH.
    JAMA; 2009 Jan 14; 301(2):165-74. PubMed ID: 19141764
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
    Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT, Cardiovascular Cell Therapy Research Network (CCTRN).
    Circulation; 2017 Apr 11; 135(15):1417-1428. PubMed ID: 28209728
    [Abstract] [Full Text] [Related]

  • 12. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial.
    McDermott MM, Bazzano L, Peterson CA, Sufit R, Ferrucci L, Domanchuk K, Zhao L, Polonsky TS, Zhang D, Lloyd-Jones D, Leeuwenburgh C, Guralnik JM, Kibbe MR, Kosmac K, Criqui MH, Tian L.
    JAMA; 2022 Oct 04; 328(13):1315-1325. PubMed ID: 36194220
    [Abstract] [Full Text] [Related]

  • 13. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR.
    J Am Geriatr Soc; 2002 Dec 04; 50(12):1939-46. PubMed ID: 12473004
    [Abstract] [Full Text] [Related]

  • 14. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.
    Fakhry F, Spronk S, van der Laan L, Wever JJ, Teijink JA, Hoffmann WH, Smits TM, van Brussel JP, Stultiens GN, Derom A, den Hoed PT, Ho GH, van Dijk LC, Verhofstad N, Orsini M, van Petersen A, Woltman K, Hulst I, van Sambeek MR, Rizopoulos D, Rouwet EV, Hunink MG.
    JAMA; 2015 Nov 10; 314(18):1936-44. PubMed ID: 26547465
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 10; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 16. Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial.
    Bearne LM, Volkmer B, Peacock J, Sekhon M, Fisher G, Galea Holmes MN, Douiri A, Amirova A, Farran D, Quirke-McFarlane S, Modarai B, Sackley C, Weinman J, Bieles J, MOSAIC Trial Collaboration.
    JAMA; 2022 Apr 12; 327(14):1344-1355. PubMed ID: 35412564
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of ankle-foot orthoses on walking ability in peripheral artery disease.
    Mays RJ, Mays AA, Mizner RL.
    Vasc Med; 2019 Aug 12; 24(4):324-331. PubMed ID: 30924412
    [Abstract] [Full Text] [Related]

  • 18. Effect of High-pressure, Intermittent Pneumatic Compression for the Treatment of Peripheral Arterial Disease and Critical Limb Ischemia in Patients Without a Surgical Option.
    Alvarez OM, Wendelken ME, Markowitz L, Comfort C.
    Wounds; 2015 Nov 12; 27(11):293-301. PubMed ID: 26574751
    [Abstract] [Full Text] [Related]

  • 19. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
    van Royen N, Schirmer SH, Atasever B, Behrens CY, Ubbink D, Buschmann EE, Voskuil M, Bot P, Hoefer I, Schlingemann RO, Biemond BJ, Tijssen JG, Bode C, Schaper W, Oskam J, Legemate DA, Piek JJ, Buschmann I.
    Circulation; 2005 Aug 16; 112(7):1040-6. PubMed ID: 16087795
    [Abstract] [Full Text] [Related]

  • 20. Community-based walking exercise for peripheral artery disease: An exploratory pilot study.
    Mays RJ, Hiatt WR, Casserly IP, Rogers RK, Main DS, Kohrt WM, Ho PM, Regensteiner JG.
    Vasc Med; 2015 Aug 16; 20(4):339-47. PubMed ID: 25755148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.